This is such good news...it’s obvious through our multiple...

This is such good news...

it’s obvious through our multiple collaboration trials that we have some serious attention within the research community.

Add in the recent statements around discussions with other potential third-party collaborators it is only a matter of time before the wider applications for Paxalisib becomes more obvious.

And with funding in place for the next 3-4 data readouts as well as the quality of the trials we are reading from it’s going to be an excellent few months ahead.